Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

NCT01118663 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cumberland Pharmaceuticals